Phio Pharmaceuticals (PHIO) Earnings Date & Reports

Phio Pharmaceuticals Corp is a clinical-stage biopharmaceutical company whose proprietary INTASYL small-interfering RNA gene silencing technology is designed to make immune cells more effective in killing tumor cells... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

PHIO is expected to report earnings to fall 13.24% to -29 cents per share on August 06

Phio Pharmaceuticals PHIO Stock Earnings Reports

Q2'26

Est.

$-0.29

Q1'26

Missed

by $0.05

Q4'25

Beat

by $0.16

Q3'25

Missed

by $0.04

Q2'25

Missed

by $0.09

The last earnings report on May 07 showed earnings per share of -34 cents, missing the estimate of -28 cents. With 49.71K shares outstanding, the current market capitalization sits at 11.85M.

View a ticker or compare two or three

Compare

PHIO

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for PHIO